conducted to find publications comparing ciNPT to standard incisional care for complex abdominal wall reconstruction. Outcomes of interest included surgical site infection, wound dehiscence, seroma, hematoma, reoperation, and readmission as overall rates and associations were pooled. A fixed effects model was used to assess between-study heterogeneity and effect size. Funnel plots were used to assess publication bias.
PURPOSE:
Parastomal hernia entails an enlargement of the original tunnel of the stoma through the abdominal wall muscle and fascia. The incidence of parastomal hernias ranges from 3% to 39%. Here, the authors describe their novel Silo technique for parastomal hernia repair which aims to increase the structural strength of the tunnel wall, reinforce the fascia above and below, and maintain a stable size of the stoma opening. The goal is to preserve the abdominal wall with in-situ repair, reduce recurrence by maintaining a stoma opening diameter of 2 to 3 cm with 3-dimensional fascial reinforcement, and reduce post-operative adhesions and infections with non-cross-linked porcine dermal matrix mesh.
METHODS:
We retrospectively analyzed twenty-three patients who underwent a parastomal hernia repair between January 2009 and June 2017 by our two senior authors using the Silo technique. Patient data extracted included demographic information, body mass index (BMI), past medical and surgical history, inpatient data, adverse outcomes, and follow-up. Primary outcome parameters were hernia recurrence, wound-related issues, and postoperative surgical complications.
RESULTS:
Twenty-three patients were identified: mean age was 65.5 years, 10 patients were male, 13 female, and average BMI was 30.4 kg/m 2 . A concomitant ventral hernia was repaired in 13 patients and 12 patients had 2 or more previous parastomal hernia repairs. Ostomy type consisted of 13 (54.2 %) colostomies, 6 (25 %) ileostomies, and 5 (20.8 %) urostomies. The average surgery lasted 324 min, and the average length of hospital stay was 7.6 days. Postoperatively, 4 patients had surgical site infections, 1 patient developed a seroma, and 1 patient experienced a wound healing delay. Readmissions encompassed 8 patients, 4 of which were due to small bowel obstruction (SBO). These 4 cases all necessitated reoperation, in addition to 1 reoperation for stoma retraction, and 1 for wound closure. Three patients were noted to have parastomal hernia recurrence during our average follow-up of 16.9 months. 2 , has been shown in microsurgical and implant reconstructions to increase postoperative complications making this population a great reconstructive challenge. With this challenge in mind, the purpose of this investigation was to evaluate the effects of microsurgical breast reconstruction and prosthetic breast reconstruction on patient reported outcomes and quality of life in obese patients.
CONCLUSION: Based on our clinical outcomes, the

METHODS:
After institutional review board approval was obtained, a retrospective review of patients who underwent breast reconstruction at Montefiore Medical Center from January of 2009 to December of 2015 was conducted. Patients with preoperative obesity were included for analysis. Patients were divided into two cohorts: those undergoing microsurgical reconstruction and prosthetic reconstruction. Patients were mailed a BREAST-Q survey for response. Additionally, the demographic information, complications, and need for revisionary procedures were analyzed in comparison. BREAST Q satisfaction was then analyzed using Q-Score software.
RESULTS: 114 patients met the inclusion criteria: 41.2 percent (n=47) of patients underwent microsurgical breast reconstruction and 58.8 percent (n=67) underwent tissue expander/ implant reconstruction. Patients in each cohort were similar in BMI, mean mastectomy specimen weight, indication for surgery, smoking status and postoperative complications. However, patients undergoing microsurgical breast reconstruction were younger (48.0 versus 53.0 years, p=0.02), more likely to have bilateral reconstruction (66.0 percent (n=31) versus 40.3 percent (n=27), p=0.007), and more likely to have delayed reconstruction (44.5 percent (n=28) versus 0.0 percent (n=0), p= 0.00001). Of those patients undergoing microsurgical reconstruction, 44.7% (n=21) responded to the BREAST-Q survey, whereas 38.8% (n=26) of patients with implant reconstruction were responders. BREAST-Q responses showed patients undergoing microsurgical breast reconstruction were more satisfied with their breasts (Q-score of 64.1 (25.3) versus 54.6 (21.0), p=0.04) and satisfaction with overall outcome (Q-score 73.5 (25.5) versus 63.5 (25.2), p=0.02). However, both cohorts had similar chest wall physical well-being, sexual well being, and psychosocial well being. Conclusions: Microsurgical breast reconstruction in obese patients yields higher satisfaction with breasts and overall outcomes as compared to implant based reconstruction. Despite increased postoperative complications associated with obese patients, microsurgical breast reconstruction appears to offer a superior reconstructive choice. This information will be important in preoperative patient discussions and counseling.
